Title |
The end-of-life phase of high-grade glioma patients: a systematic review
|
---|---|
Published in |
Supportive Care in Cancer, December 2013
|
DOI | 10.1007/s00520-013-2088-9 |
Pubmed ID | |
Authors |
Eefje M. Sizoo, H. Roeline W. Pasman, Linda Dirven, Christine Marosi, Wolfgang Grisold, Günther Stockhammer, Jonas Egeter, Robin Grant, Susan Chang, Jan J. Heimans, Luc Deliens, Jaap C. Reijneveld, Martin J. B. Taphoorn |
Abstract |
High-grade gliomas (HGG) are rare and incurable; yet, these neoplasms result in a disproportionate share of cancer morbidity and mortality. Treatment of HGG patients is directed not merely towards prolonging life but also towards quality of life, which becomes the major goal in the end of life (EOL). The latter has received increasing attention over the last decade. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Canada | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 126 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 17 | 13% |
Student > Ph. D. Student | 15 | 12% |
Student > Master | 14 | 11% |
Student > Postgraduate | 9 | 7% |
Student > Bachelor | 9 | 7% |
Other | 23 | 18% |
Unknown | 42 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 37 | 29% |
Nursing and Health Professions | 18 | 14% |
Psychology | 10 | 8% |
Engineering | 5 | 4% |
Social Sciences | 4 | 3% |
Other | 6 | 5% |
Unknown | 49 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2014.
All research outputs
#15,289,831
of 22,738,543 outputs
Outputs from Supportive Care in Cancer
#3,071
of 4,554 outputs
Outputs of similar age
#192,715
of 307,717 outputs
Outputs of similar age from Supportive Care in Cancer
#38
of 60 outputs
Altmetric has tracked 22,738,543 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,554 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,717 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.